- NATURE PODCAST
Nature reporters discuss the country-music icon's advocacy for vaccines and public health — plus, promising trial results for an mRNA cancer therapy.
By
- Benjamin Thompson
- Elizabeth Gibney
Download the Nature Briefing Podcast 28 August 2026
In this episode:
00:18 Researchers celebrate Dolly Parton's contributions to science
Nature: Dolly Parton dies aged 80 — researchers celebrate her contributions to science
08:40 Phase III trial of melanoma vaccine shows promise
Nature: Moderna cancer vaccine stops melanoma returning: what’s next for personalized treatments?
Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.
Never miss an episode. Subscribe to the Nature Podcast on Apple Podcasts, Spotify, YouTube Music or your favourite podcast app. An RSS feed for the Nature Podcast is available too.
doi: https://doi.org/10.1038/d41586-026-02732-w
Related Articles
-
Dolly at 20: The inside story on the world’s most famous sheep
-
Music is not a universal language — but it can bring us together when words fail
-
How personalized cancer vaccines could keep tumours from coming back
Subjects
Latest on:
- Communication
- Funding
- Cancer
-
Dolly Parton dies aged 80 — researchers celebrate her contributions to science
News
-
Ancient surveying instrument found in Egypt
News & Views
-
Science-backed tips on how to avoid distractions
Career Feature
-
Dolly Parton dies aged 80 — researchers celebrate her contributions to science
News
-
A guide to securing your first research fellowship: what reviewers are looking for
Career Column
-
Frontier-technology markets are too narrow — here’s how to widen them
Comment
-
The Moderna cancer vaccine offers hope — now we must speed up personalized therapies
World View
-
A binding-to-release strategy for targeted anticancer drug delivery
Article
-
Sleuth identifies dozens of studies that used the wrong antibody
News